DrugDashboards

eribulin mesylate

eribulin mesylate · ERIBULIN MESYLATE .5 mg/mL · Injection · Intravenous · Apotex Corp.

NDC 60505-6435-00 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $7,026.49 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA218047
TE code
AP
Approval date
Apr 5, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of eribulin mesylate (Injection)

LabelerStrengthFirst seenLast seen
Apotex Corp.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CompanyERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
BSP Pharmaceuticals SpAERIBULIN MESYLATE 1 mg/2mLJul 15, 2026Sep 2, 2026
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddys Laboratories IncERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Eisai Inc.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Kindos Pharmaceuticals Co., Ltd.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries LimitedERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026
XGen Pharmaceuticals DJB, Inc.ERIBULIN MESYLATE .5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "eribulin mesylate — NDC 60505-6435-00," retrieved September 3, 2026, https://drugdashboards.com/drug/60505643500.

Free to cite with attribution — see how the data is put together.